PetMed Express (NASDAQ:PETS) Stock Passes Above 200-Day Moving Average - Time to Sell?

PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.25 and traded as high as $5.00. PetMed Express shares last traded at $4.99, with a volume of 213,574 shares trading hands.

Analysts Set New Price Targets

Separately, StockNews.com raised PetMed Express from a "hold" rating to a "buy" rating in a report on Tuesday, November 12th.

PetMed Express Stock Performance

The firm has a fifty day moving average price of $5.08 and a two-hundred day moving average price of $4.25. The stock has a market capitalization of $103.71 million, a P/E ratio of -83.67 and a beta of 0.69.

PetMed Express (NASDAQ:PETS - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.17. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. The firm had revenue of $59.57 million for the quarter, compared to analysts' expectations of $66.02 million. On average, research analysts anticipate that PetMed Express, Inc. will post 0.24 earnings per share for the current fiscal year.

Insider Buying and Selling

In other PetMed Express news, Director Leslie C.G. Campbell purchased 15,000 shares of the business's stock in a transaction on Wednesday, December 4th. The stock was acquired at an average price of $5.38 per share, for a total transaction of $80,700.00. Following the purchase, the director now owns 70,000 shares of the company's stock, valued at approximately $376,600. This represents a 27.27 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.10% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in PETS. Sei Investments Co. grew its position in shares of PetMed Express by 8.3% during the second quarter. Sei Investments Co. now owns 44,220 shares of the company's stock valued at $179,000 after purchasing an additional 3,400 shares in the last quarter. Marshall Wace LLP purchased a new position in shares of PetMed Express during the second quarter valued at about $46,000. Cubist Systematic Strategies LLC purchased a new position in shares of PetMed Express during the second quarter valued at about $797,000. Squarepoint Ops LLC purchased a new position in PetMed Express in the second quarter worth about $273,000. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in PetMed Express in the second quarter worth about $135,000. Hedge funds and other institutional investors own 73.33% of the company's stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.